Loading
Xstrahl is a British maker of superficial and orthovoltage X-ray therapy machines for skin cancer and of preclinical radiation research platforms.
Xstrahl, whose FDA filings give an address in Brownhills, England, holds clearances for its Photoelectric Therapy System (K172080, 2017) and the RADiant line (K230611, 2023), which it says is "designed to bring non-surgical treatment options to office-based dermatology practices to treat non-melanoma skin cancer and keloid scarring". Its Xstrahl 100, 150, 200 and 300 orthovoltage units are on its website; no FDA record under those names was found.
Shares Superficial and orthovoltage radiotherapy for skin cancer, Brachytherapy, intraoperative and skin radiotherapy machines: afterloaders, theatre linacs and office X-ray units and the tag machines-wave3.
Shares Brachytherapy, intraoperative and skin radiotherapy machines: afterloaders, theatre linacs and office X-ray units and the tag machines-wave3.
Shares Superficial and orthovoltage radiotherapy for skin cancer, Brachytherapy, intraoperative and skin radiotherapy machines: afterloaders, theatre linacs and office X-ray units and the tag machines-wave3.
Shares Brachytherapy, intraoperative and skin radiotherapy machines: afterloaders, theatre linacs and office X-ray units and the tag machines-wave3.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/